Drug intelligence / Profile preview

coptidis rhizoma

Development stage
Phase 1
Modality
Small Molecules
Administration
Oral, Topical
01

Overview

Coptidis rhizoma is the dried rhizome of Coptis chinensis Franch., C. deltoidea C.Y. Cheng et Hsiao, or C. teeta Wall (family Ranunculaceae), widely known in Chinese as "Huanglian." It is a traditional herbal medicine used extensively in China and other parts of Asia for its broad pharmacological effects. The main active constituents are isoquinoline alkaloids—most notably berberine—as well as jateorrhizine, palmatine, and coptisine[1][5]. These compounds confer antibacterial, antiviral, antifungal, antidiabetic, anticancer and cardioprotective properties[1][4]. In traditional Chinese medicine (TCM), it is used to "clear damp-heat," "quench fire," and "counteract poison." Modern research has confirmed its efficacy particularly in treating type 2 diabetes (with hypoglycemic effects), bacillary dysentery (antimicrobial action), sore throat (anti-inflammatory effect), eczema (anti-inflammatory/antimicrobial) and other conditions[1][5]. Berberine acts through multiple mechanisms including inhibition of bacterial DNA synthesis and modulation of glucose metabolism pathways; however it can be toxic at high doses[1][5].

Other names
huanglianrhizoma coptidisgoldthreadcoptis root
02

Targets

AMPK (Adenosine monophosphate–activated protein kinase)TNFA (Tumor necrosis factor alpha (soluble))FtsZ (Filamentous temperature-sensitive protein Z)CMV DNA polymerase (Human cytomegalovirus DNA polymerase)VEGFA (Vascular endothelial growth factor A)IL-6 (Interleukin 6)

Beyond the preview

Go deeper on coptidis rhizoma.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on coptidis rhizoma.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call